<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01498146</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2010-014</org_study_id>
    <nct_id>NCT01498146</nct_id>
  </id_info>
  <brief_title>Finding Atrial Fibrillation in Patients With Unexplained Stroke Using Longterm Cardiac Monitoring</brief_title>
  <acronym>SURPRISE</acronym>
  <official_title>Stroke Prior to Diagnosis of Atrial Fibrillation Using Longterm Observation With Implantable Cardiac Monitoring Apparatus Reveal(SURPRISE) -the SURPRISE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SURPRISE study investigates atrial fibrillation(AFIB) in patients with a previous&#xD;
      unexplained stroke. It uses long term monitoring of the heart of up to three years, searching&#xD;
      for paroxysmal atrial fibrillation(PAF) otherwise undetected in this population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SURPRISE study investigates the patients with cryptogenic stroke or transient ischemic&#xD;
      attack (TIA), monitoring them with a cardiac loop recorder for up to three years.&#xD;
&#xD;
      it aims at estimating the amount of paroxysmal atrial fibrillation within our population of&#xD;
      cryptogenic stroke patients.&#xD;
&#xD;
      Standard workup for a stroke patient does offer cardiac evaluation, but monitoring is limited&#xD;
      to the time admitted, often just a few days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">85</enrollment>
  <condition>Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        the patients are included from the investigators stroke unit and day clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Computerized Tomography (CT) or Magnetic resonance imaging (MRI) verified cryptogenic&#xD;
             stroke or TIA;&#xD;
&#xD;
          -  &gt; 18 years of age,&#xD;
&#xD;
          -  the ability to provide a written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  prior or known AFIB&#xD;
&#xD;
          -  AF found during work up including 24 hour telemetric monitoring.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanne Christensen, MD, PhD, DMSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital, University Hospital of Copenhagen, dept of Neurology</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 21, 2011</study_first_submitted>
  <study_first_submitted_qc>December 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2011</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Hanne Christensen</investigator_full_name>
    <investigator_title>Associate Research Professor, Consultant neurologist</investigator_title>
  </responsible_party>
  <keyword>cryptogenic stroke</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>longterm monitoring</keyword>
  <keyword>loop recorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

